← Leaderboards
Peter C. Melby
University Of Texas Hlth Sci Ctr San Ant
$7,526,878
Attributed
$7,917,495
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $737.5K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,917,495 · 9
By mechanism
R01$5,224,366 · 3
R24$875,670 · 1
T32$775,235 · 1
RC1$499,826 · 1
R21$426,188 · 1
R03$110,210 · 1
Top collaborators
- Slobodan Paessler5 shared
- Susan Leslie Favrot Mclellan1 shared
Most similar at University Of Texas Hlth Sci Ctr San Ant
Same institution · by research overlap
- Andrew P Hinck$7,633,012
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionCytokineResponseParasitesCutaneousCessation Of LifeChemokinePathogenesisHamstersVisceralVisceral LeishmaniasisMediatingAnimalsSkinProductionLeishmania DonovaniLeadInflammationInvestigationEnzyme Linked Immunosorbent AssayMacrophageTrainingLeishmania (Genus)Pathogen
Grant awards (30)
Physician-Scientist Training in Emerging Infectious Diseases$207,348
T32 · FY2025 · AI · contact PI
Physician-Scientist Training in Emerging Infectious Diseases$102,304
T32 · FY2024 · AI · contact PI
Tropical and Emerging Infectious Diseases for the Clinician and Translational Investigator$6,000
R13 · FY2024 · AI · contact PI
Physician-Scientist Training in Emerging Infectious Diseases$186,789
T32 · FY2023 · AI · contact PI
Mechanisms of Parasite Dissemination in Visceral Leishmaniasis$548,179
R01 · FY2022 · AI · contact PI
Physician-Scientist Training in Emerging Infectious Diseases$189,338
T32 · FY2022 · AI · contact PI
Mechanisms of Parasite Dissemination in Visceral Leishmaniasis$548,179
R01 · FY2021 · AI · contact PI
Physician-Scientist Training in Emerging Infectious Diseases$89,456
T32 · FY2021 · AI · contact PI
Mechanisms of Parasite Dissemination in Visceral Leishmaniasis$548,179
R01 · FY2020 · AI · contact PI
Mechanisms of Parasite Dissemination in Visceral Leishmaniasis$548,179
R01 · FY2019 · AI · contact PI
Mechanisms of Parasite Dissemination in Visceral Leishmaniasis$566,377
R01 · FY2018 · AI · contact PI
Malnutrition-related Lymph Node Dysfunction and Risk of Visceral Leishmaniasis$193,750
R21 · FY2015 · AI · contact PI
Malnutrition-related Lymph Node Dysfunction and Risk of Visceral Leishmaniasis$232,438
R21 · FY2014 · AI · contact PI
NOS2 and arginase in visceral leishmaniasis-FIRCA supplement$36,200
R03 · FY2011 · TW · contact PI
Discovery of 4-aminoquinoline therapeutics for visceral leishmaniasis$499,826
RC1 · FY2010 · AI · contact PI
NOS2 and arginase in visceral leishmaniasis-FIRCA supplement$33,788
R03 · FY2010 · TW · contact PI
NOS2 and arginase in visceral leishmaniasis$289,514
R01 · FY2009 · AI · contact PI
NOS2 and arginase in visceral leishmaniasis-FIRCA supplement$40,222
R03 · FY2009 · TW · contact PI
NOS2 and arginase in visceral leishmaniasis$289,514
R01 · FY2008 · AI · contact PI
NOS2 and arginase in visceral leishmaniasis$295,121
R01 · FY2007 · AI · contact PI
NOS2 and arginase in visceral leishmaniasis$303,936
R01 · FY2006 · AI · contact PI
NOS2 and arginase in visceral leishmaniasis$311,250
R01 · FY2005 · AI
VACCINATION OF DOGS TO REDUCE TRANSMISSION OF LEISHMANIA$311,494
R01 · FY2003 · AI
MOLECULAR TOOLS TO DEVELOP HAMSTER MODELS OF DISEASE$188,305
R24 · FY2003 · RR
VACCINATION OF DOGS TO REDUCE TRANSMISSION OF LEISHMANIA$313,090
R01 · FY2002 · AI
MOLECULAR TOOLS TO DEVELOP HAMSTER MODELS OF DISEASE$242,092
R24 · FY2002 · RR
VACCINATION OF DOGS TO REDUCE TRANSMISSION OF LEISHMANIA$351,354
R01 · FY2001 · AI
MOLECULAR TOOLS TO DEVELOP HAMSTER MODELS OF DISEASE$238,168
R24 · FY2001 · RR
MOLECULAR TOOLS TO DEVELOP HAMSTER MODELS OF DISEASE$13,775
R24 · FY2001 · RR
MOLECULAR TOOLS TO DEVELOP HAMSTER MODELS OF DISEASE$193,330
R24 · FY2000 · RR